SCHEMBL6662718

SCHEMBL6662718

Cn1cnc2c(-c3ccccc3)ncnc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.52
ADORA1 P30542 3/20 0.51
ADORA2A P29274 3/20 0.51
PIK3CD O00329 3/20 0.51
PIK3R1 P27986 2/20 0.51
YTHDC1 Q96MU7 1/20 0.49
NSD3 Q9BZ95 1/20 0.45
P2RX7 Q99572 1/20 0.44
FLT1 P17948 1/20 0.42
KDR P35968 1/20 0.42
TEK Q02763 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2B P29275 1/20 0.42
PI4KA P42356 1/20 0.42
PI4K2B Q8TCG2 1/20 0.42
PI4K2A Q9BTU6 1/20 0.42
PI4KB Q9UBF8 1/20 0.42
FGFR1 P11362 1/20 0.42
FGFR4 P22455 1/20 0.42
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29842526 1.00 CDK1 (0.52) CDK1ADORA1ADORA2APIK3CDPIK3R1
SCHEMBL28739971 0.85 ADORA1 (0.50) CDK1ADORA1ADORA2APIK3CDPIK3R1
SCHEMBL6663756 0.83 ADORA1 (0.49) CDK1ADORA1ADORA2APIK3CDPIK3R1
SCHEMBL13137092 0.81 ADORA1 (0.46) CDK1ADORA1ADORA2APIK3CDPIK3R1
SCHEMBL26977659 0.79 P2RX7 (0.47) ADORA1ADORA2APIK3CDPIK3R1P2RX7
SCHEMBL28295500 0.77 MAPK14 (0.49) CDK1ADORA1ADORA2ANSD3ADORA3
SCHEMBL31042997 0.76 CDK1 (0.56) CDK1YTHDC1NSD3
SCHEMBL27825327 0.76 P2RX7 (0.53) ADORA1ADORA2AP2RX7PI4KAPI4K2B
SCHEMBL29096112 0.74 ADORA2A (0.67) ADORA2AP2RX7PI4KAPI4K2BPI4K2A
SCHEMBL22449904 0.73 ADORA2A (0.54) ADORA1ADORA2AADORA3ADORA2BPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444982-A1 The use of purine derivatives as selective kinase inhibitors MERCKLE GMBH (DE) 2004-08-11 EP disclosed